METHOD OF PRODUCING PLANT-DERIVED EXOSOMES
    1.
    发明公开

    公开(公告)号:US20230183642A1

    公开(公告)日:2023-06-15

    申请号:US17924699

    申请日:2021-05-10

    IPC分类号: C12N5/04

    CPC分类号: C12N5/04

    摘要: A method of producing plant-derived exosomes from plant tissue culture based cell suspension cultures is provided. The method includes: obtaining the plant tissue culture based cell suspension culture; mixing the the plant tissue culture based cell suspension culture with an isolation solution; centrifuging to obtain a supernatant and an infranatant; and obtaining the plant-derived exosomes from the infranatant. The objective of the present invention is to produce homogenous plant exosomes with high volume and purity by making use of the advantages of the plant suspension culture to be used for purposes such as therapeutics and drug carriers.

    CHEMOTHERAPEUTIC DRUG COMBINATION
    4.
    发明申请
    CHEMOTHERAPEUTIC DRUG COMBINATION 有权
    化疗药物组合

    公开(公告)号:US20160346325A1

    公开(公告)日:2016-12-01

    申请号:US15114854

    申请日:2015-01-14

    IPC分类号: A61K33/34 A61K31/77 A61K33/32

    摘要: The present invention relates to a chemotherapeutic drug combination containing heterodinuclear Cu (II)-Mn(II) complex. The objective of the present invention is to provide a drug combination, which will be actively used in chemotherapy, is anticarcinogenic and has no side effects, facilitates penetration into the cell, shows selectivity only for cancer cells and does not harm healthy cells, and is not toxic for the tissues and organs in the body, and which can prepared easily and provides a definitive and fast treatment.

    摘要翻译: 本发明涉及含有异二核Cu(II)-Mn(II)配合物的化疗药物组合。 本发明的目的是提供一种药物组合,其主要用于化学疗法,具有抗癌作用,无副作用,有利于细胞渗透,仅对癌细胞具有选择性,不会损害健康细胞,而且 对身体中的组织和器官没有毒性,并且可以容易地制备并提供确定和快速的治疗。

    USE OF PLANT EXOSOMES FOR SHOWING MODULATING EFFECTS ON IMMUNE SYSTEM CELLS

    公开(公告)号:US20210353747A1

    公开(公告)日:2021-11-18

    申请号:US17273994

    申请日:2019-09-03

    IPC分类号: A61K39/39 A61K47/46

    摘要: Use of the effects of plant exosomes on the immune system as immune system enhancers, silencers and modulators against diseases is disclosed. The plant derived exosomes are obtained from at least one portion of the plant selected from the group consisting of the entire plant, fruit, leaf, seed, root, or differentiated tissues like the plant's tissue culture medium, stem cell, waste material, shell or phloem. In the scope of the invention, the plant exosomes having immunomodulatory effects are used mainly in autoimmune diseases, and in cell, tissue, organ transplantations and in Graft Versus Host disease as immune system enhancers, suppressors or, if necessary, as modulators performing both of the first two functions.

    PRODUCT CONTAINING PLANT DERIVED EXOSOMES
    9.
    发明申请

    公开(公告)号:US20200230196A1

    公开(公告)日:2020-07-23

    申请号:US16482719

    申请日:2018-01-31

    摘要: A product containing plant derived exosome that may be used in cancer treatment and wound healing. The product enables to provide a low-cost product, which does not cause toxic effects in human body, does not cause damage in the healthy cells during the course of the cancer treatment, does not pose any infection risk since it does not require any procedure such as radiotherapy or surgery, and the side effects occurring in chemotherapy treatment are not experienced. Wheatgrass, garlic and ginger can be used alone or in combination in the product as the plant source.